These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37536993)

  • 1. [Advances in the diagnosis and treatment strategy of polymyxin resistant
    Chen YX; Xu YP; Zhu YG; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):813-818. PubMed ID: 37536993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
    Lu J; Han M; Yu HH; Bergen PJ; Liu Y; Zhao J; Wickremasinghe H; Jiang X; Hu Y; Du H; Zhu Y; Velkov T
    Microbiol Spectr; 2023 Aug; 11(4):e0085223. PubMed ID: 37432123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4-Hexylresorcinol on the Efficiency of Antibiotic Treatment of Experimental Sepsis Caused by Antibiotic-Resistant Klebsiella pneumoniae Strain in Mice.
    Shemyakin IG; Manzenyuk OY; El'-Registan GI; Firstova VV; Kombarova TI; Gneusheva TY; Kyazimov EI; Nikolaev YA
    Bull Exp Biol Med; 2021 Aug; 171(4):458-460. PubMed ID: 34542762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
    Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
    Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
    Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of polymyxin and vancomycin combinations on carbapenem- and polymyxin-resistant
    Nwabor OF; Chukamnerd A; Terbtothakun P; Nwabor LC; Surachat K; Roytrakul S; Voravuthikunchai SP; Chusri S
    Microbiol Spectr; 2023 Dec; 11(6):e0119923. PubMed ID: 37905823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
    Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.
    Macesic N; Nelson B; Mcconville TH; Giddins MJ; Green DA; Stump S; Gomez-Simmonds A; Annavajhala MK; Uhlemann AC
    Clin Infect Dis; 2020 May; 70(10):2084-2091. PubMed ID: 31513705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of cinnamaldehyde against multidrug-resistant Klebsiella pneumoniae: an in vitro and in vivo study.
    Vaz MSM; de Almeida de Souza GH; Dos Santos Radai JA; Fraga TL; de Oliveira GG; Wender H; da Silva KE; Simionatto S
    Braz J Microbiol; 2023 Sep; 54(3):1655-1664. PubMed ID: 37392293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
    Zhang X; Guo F; Shao H; Zheng X
    J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
    Aye SM; Galani I; Yu H; Wang J; Chen K; Wickremasinghe H; Karaiskos I; Bergen PJ; Zhao J; Velkov T; Giamarellou H; Lin YW; Tsuji BT; Li J
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling synergism of polymyxin B with chloramphenicol derivatives against multidrug-resistant (MDR) Klebsiella pneumoniae.
    Idris N; Leong KH; Wong EH; Abdul Rahim N
    J Antibiot (Tokyo); 2023 Dec; 76(12):711-719. PubMed ID: 37821539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.
    Zavascki AP; Girardello R; Magagnin CM; Antochevis LC; Maciel RA; Palmeiro JK; Gales AC
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):134-138. PubMed ID: 29150371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
    Borjan J; Meyer KA; Shields RK; Wenzler E
    Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Sun L; Sun J; Ding S
    J Int Med Res; 2022 Jun; 50(6):3000605221106705. PubMed ID: 35711149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae.
    Gaspar GG; Bellissimo-Rodrigues F; Andrade LN; Darini AL; Martinez R
    Rev Soc Bras Med Trop; 2015; 48(4):483-7. PubMed ID: 26132495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.